The global red biotechnology market was valued at USD 531.66 billion in 2024, with a projected CAGR of 10.31% anticipated from 2025 to 2034. This trajectory is being significantly influenced by key countries such as the United States, China, Germany, and Japan, each contributing to global revenue through strategic R&D initiatives, robust local manufacturing bases, and well-established...